PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Cancer 1,053,491 Disease Target Carbonic Anhydrase 9 150 80 0.01 -0.68 0.53 0.59
Cancer 1,053,491 Disease Disease Leukemias 14,152 1,978 0.02 -0.93 0.14 0.59
Cancer 1,053,491 Disease Target Multidrug Resistance Protein 1 495 183 0.01 -0.79 0.37 0.59
Cancer 1,053,491 Disease Drug Doxorubicin Hydrochloride 581 204 0.01 -0.81 0.35 0.59
Cancer 1,053,491 Disease Disease Anemia 81,663 6,673 0.02 -0.96 0.08 0.58
Cancer 1,053,491 Disease Target DAPK1 205 94 0.01 -0.74 0.46 0.58
Cancer 1,053,491 Disease Target AKT3 293 117 0.01 -0.77 0.40 0.58
Cancer 1,053,491 Disease Target Ret Proto-Oncogene 1,005 281 0.01 -0.85 0.28 0.58
Cancer 1,053,491 Disease Disease Warts 5,574 942 0.01 -0.91 0.17 0.58
Cancer 1,053,491 Disease Target ERBB4 994 273 0.01 -0.85 0.27 0.58
Cancer 1,053,491 Disease Target Hypoxia-Inducible Factor 1-Alpha 923 257 0.01 -0.85 0.28 0.58
Cancer 1,053,491 Disease Target Aurora A kinase 318 118 0.01 -0.79 0.37 0.58
Cancer 1,053,491 Disease Drug Alimta (Pemetrexed)- FDA 28 20 0.00 -0.53 0.71 0.58
Cancer 1,053,491 Disease Drug Anastrozole (Arimidex)- FDA 10 9 0.00 -0.32 0.90 0.58
Cancer 1,053,491 Disease Target APO-2L 90 44 0.00 -0.71 0.49 0.58
Cancer 1,053,491 Disease Drug Doxoform 9 8 0.00 -0.33 0.89 0.58
Cancer 1,053,491 Disease Drug Doxazolidine 9 8 0.00 -0.33 0.89 0.58
Cancer 1,053,491 Disease Target Cytokeratin 8 587 162 0.01 -0.85 0.28 0.58
Cancer 1,053,491 Disease Disease Fibrocystic Breast Disease 173 65 0.00 -0.79 0.38 0.58
Cancer 1,053,491 Disease Target Cytokeratin 18 1,108 249 0.01 -0.88 0.22 0.58
Cancer 1,053,491 Disease Target AXL 633 165 0.01 -0.86 0.26 0.58
Cancer 1,053,491 Disease Drug Aromasin (Exemestane)- FDA 7 6 0.00 -0.38 0.86 0.58
Cancer 1,053,491 Disease Target Kallikrein-6 79 35 0.00 -0.75 0.44 0.58
Cancer 1,053,491 Disease Target Epiregulin 291 91 0.01 -0.83 0.31 0.58
Cancer 1,053,491 Disease Target Equilibrative Nucleoside Transporter 1 211 71 0.00 -0.81 0.34 0.58
Cancer 1,053,491 Disease Disease Skin Rash 3,684 578 0.01 -0.92 0.16 0.58
Cancer 1,053,491 Disease Disease Constipation 15,810 1,685 0.01 -0.94 0.11 0.58
Cancer 1,053,491 Disease Disease Infection 766,637 29,273 0.03 -0.97 0.04 0.58
Cancer 1,053,491 Disease Target CYR61 539 138 0.01 -0.86 0.26 0.58
Cancer 1,053,491 Disease Target Methylenetetrahydrofolate Reductase 3,573 555 0.01 -0.92 0.16 0.58
Cancer 1,053,491 Disease Disease Inflammatory Bowel Disease 24,375 2,269 0.01 -0.95 0.09 0.58
Cancer 1,053,491 Disease Target EPHB4 329 94 0.01 -0.85 0.29 0.58
Cancer 1,053,491 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 6 0.00 -0.50 0.75 0.58
Cancer 1,053,491 Disease Disease Osteoporosis 46,215 3,605 0.02 -0.96 0.08 0.57
Cancer 1,053,491 Disease Drug Axitinib (Inlyta)- FDA 10 7 0.00 -0.55 0.70 0.57
Cancer 1,053,491 Disease Target Galectin-1 1,131 229 0.01 -0.89 0.20 0.57
Cancer 1,053,491 Disease Target BRK 236 70 0.00 -0.84 0.30 0.57
Cancer 1,053,491 Disease Drug Abarelix (Plenaxis)- FDA 5 4 0.00 -0.45 0.80 0.57
Cancer 1,053,491 Disease Disease Gynecomastia 2,594 407 0.01 -0.92 0.16 0.57
Cancer 1,053,491 Disease Disease Carcinoma Prostate 68 27 0.00 -0.78 0.40 0.57
Cancer 1,053,491 Disease Target EPHB2 385 97 0.00 -0.86 0.25 0.57
Cancer 1,053,491 Disease Disease Carcinoma Squamous Cell 47 20 0.00 -0.76 0.43 0.57
Cancer 1,053,491 Disease Disease Dyspnea 24,781 2,140 0.01 -0.95 0.09 0.57
Cancer 1,053,491 Disease Target CD34 24,598 2,119 0.01 -0.95 0.09 0.57
Cancer 1,053,491 Disease Target Kallikrein-8 19 10 0.00 -0.69 0.53 0.57
Cancer 1,053,491 Disease Target Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 4 3 0.00 -0.50 0.75 0.57
Cancer 1,053,491 Disease Target Endoglin 1,333 232 0.01 -0.91 0.17 0.57
Cancer 1,053,491 Disease Disease Carcinoma Renal 6 4 0.00 -0.58 0.67 0.57
Cancer 1,053,491 Disease Target CD95 4,266 541 0.01 -0.93 0.13 0.57
Cancer 1,053,491 Disease Drug Adriamycin PFS (Doxorubicin hydrochloride)- FDA 1 1 0.00 -0.71 1.00 0.57